Targeting Neural Circuits.
Optogenetic methodology enables direct targeting of specific neural circuit elements for inhibition or excitation while spanning timescales from the acute (milliseconds) to the chronic (many days or more). Although the impact of this temporal versatility and cellular specificity has been greater for basic science than clinical research, it is natural to ask whether the dynamic patterns of neural circuit activity discovered to be causal in adaptive or maladaptive behaviors could become targets for treatment of neuropsychiatric diseases. Here, we consider the landscape of ideas related to therapeutic targeting of circuit dynamics. Specifically, we highlight optical, ultrasonic, and magnetic concepts for the targeted control of neural activity, preclinical/clinical discovery opportunities, and recently reported optogenetically guided clinical outcomes.
Department of Bioengineering, Stanford University, Stanford, CA 94305, USA.
Priyamvada
P
Rajasethupathy
Department of Bioengineering, Stanford University, Stanford, CA 94305, USA.
Emily
E
Ferenczi
Department of Bioengineering, Stanford University, Stanford, CA 94305, USA; Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford, CA 94305, USA; Howard Hughes Medical Institute, Stanford University, Stanford, CA 94305, USA. Electronic address: deissero@stanford.edu.
Karl
K
Deisseroth
D000818:Animals; D001921:Brain / Q000166:cytology / Q000502:physiology*; D055590:Electromagnetic Phenomena; D006801:Humans; D009434:Neural Pathways; D009474:Neurons / Q000502:physiology; D055355:Opsins / Q000502:physiology; D062308:Optogenetics / Q000379:methods*
D055355:Opsins